Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Gains from Investment Securities (2023 - 2025)

Ardent Health has reported Gains from Investment Securities over the past 3 years, most recently at $36.4 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $36.4 million for Q4 2025, up 3658.31% from a year ago — trailing twelve months through Dec 2025 was $36.5 million (up 2038.84% YoY), and the annual figure for FY2025 was $36.5 million, up 2038.84%.
  • Gains from Investment Securities for Q4 2025 was $36.4 million at Ardent Health, up from -$172000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ARDT hit a ceiling of $36.4 million in Q4 2025 and a floor of -$236000.0 in Q3 2023.
  • Median Gains from Investment Securities over the past 3 years was $214000.0 (2025), compared with a mean of $6.2 million.
  • Peak annual rise in Gains from Investment Securities hit 3658.31% in 2025, while the deepest fall reached 121.61% in 2025.
  • Ardent Health's Gains from Investment Securities stood at $18.1 million in 2023, then plummeted by 94.65% to $969000.0 in 2024, then skyrocketed by 3658.31% to $36.4 million in 2025.
  • The last three reported values for Gains from Investment Securities were $36.4 million (Q4 2025), -$172000.0 (Q3 2025), and $50000.0 (Q2 2025) per Business Quant data.